JPH02176A - 酢酸誘導体およびその塩類 - Google Patents

酢酸誘導体およびその塩類

Info

Publication number
JPH02176A
JPH02176A JP63312575A JP31257588A JPH02176A JP H02176 A JPH02176 A JP H02176A JP 63312575 A JP63312575 A JP 63312575A JP 31257588 A JP31257588 A JP 31257588A JP H02176 A JPH02176 A JP H02176A
Authority
JP
Japan
Prior art keywords
group
carboxy
chlorothiazol
compound
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63312575A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0359070B2 (enExample
Inventor
Takao Takatani
高谷　隆男
Hisashi Takasugi
高杉　寿
Masayoshi Murata
正好 村田
Akiteru Yoshioka
吉岡　明昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPH02176A publication Critical patent/JPH02176A/ja
Publication of JPH0359070B2 publication Critical patent/JPH0359070B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP63312575A 1980-12-31 1988-12-09 酢酸誘導体およびその塩類 Granted JPH02176A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8041635 1980-12-31
GB8041635 1980-12-31
GB8108991 1981-03-23
GB8108991 1981-03-23
GB8126500 1981-09-01
GB8126500 1981-09-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP15682A Division JPS57131794A (en) 1980-12-31 1981-12-29 Novel cephem compound or salt thereof, preparation of the same and preventing agent and remedy for microbism containing the same as active constituent

Publications (2)

Publication Number Publication Date
JPH02176A true JPH02176A (ja) 1990-01-05
JPH0359070B2 JPH0359070B2 (enExample) 1991-09-09

Family

ID=27261079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63312575A Granted JPH02176A (ja) 1980-12-31 1988-12-09 酢酸誘導体およびその塩類

Country Status (4)

Country Link
US (3) US4438113A (enExample)
EP (1) EP0055465B1 (enExample)
JP (1) JPH02176A (enExample)
DE (1) DE3177090D1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016512257A (ja) * 2013-03-13 2016-04-25 セラヴァンス バイオファーマ アンチバイオティクス アイピー， エルエルシー 置換チアゾリル酢酸トリエチルアミン塩の結晶形態

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
DE3177090D1 (en) * 1980-12-31 1989-09-28 Fujisawa Pharmaceutical Co 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
GB8704621D0 (en) * 1987-02-27 1987-04-01 Glaxo Group Ltd Chemical compounds
GB9519883D0 (en) * 1995-09-29 1995-11-29 Fujisawa Pharmaceutical Co New cephem compounds
EP1059293A1 (en) * 1995-10-12 2000-12-13 Microcide Pharmaceuticals, Inc. Novel amino chlorothiazole compounds
IT1295935B1 (it) * 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
US6723290B1 (en) * 1998-03-07 2004-04-20 Levine Robert A Container for holding biologic fluid for analysis
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
KR101403164B1 (ko) 2005-12-07 2014-06-03 바실리어 파마슈티카 아게 베타-락타마아제 저해제 및 모노박탐 항생물질의 유용한조합
US9579651B2 (en) 2009-12-18 2017-02-28 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge
ES2533839T3 (es) 2010-12-30 2015-04-15 Abbott Point Of Care, Inc. Cartucho de análisis de fluido biológico con porción de manipulación de muestra y porción de cámara de análisis
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN110892247B (zh) 2017-08-17 2023-08-25 雅培医护站股份有限公司 用于执行光学和电化学测定的设备、系统和方法
CN110869745B (zh) 2017-08-17 2023-08-11 雅培医护站股份有限公司 用于执行光学测定的设备、系统和方法
WO2019035082A1 (en) 2017-08-17 2019-02-21 Abbott Point Of Care Inc. TECHNIQUES FOR PERFORMING OPTICAL AND ELECTROCHEMICAL ASSAYS WITH UNIVERSAL CIRCUITS
WO2020243741A1 (en) 2019-05-28 2020-12-03 Levine Robert A Apparatus and method for transferring and analyzing suspended particles in a liquid sample

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971778A (en) 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4152433A (en) * 1976-03-12 1979-05-01 Fujisawa Pharmaceutical Co., Ltd. 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and pharmaceutical compositions
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
DE2758001A1 (de) * 1977-12-24 1979-07-12 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
FR2421907A1 (fr) 1978-04-07 1979-11-02 Roussel Uclaf Nouvelles cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl)2-(carboxymethoxyimino/acetamido 3-substitue cephalosporanique, leur procede de preparation et leur application comme medicaments
GB2034692B (en) * 1978-09-08 1982-12-01 Fujisawa Pharmaceutical Co Cephem compounds and processes for preparation thereof
JPS5543011A (en) 1978-09-20 1980-03-26 Shionogi & Co Ltd 7-halothiazolylalkoxyiminoacetamido-3-cephem compound
EP0088454B1 (en) * 1979-09-03 1986-03-05 Fujisawa Pharmaceutical Co., Ltd. New starting compounds for preparing cephem compounds and processes for their preparation
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3177090D1 (en) * 1980-12-31 1989-09-28 Fujisawa Pharmaceutical Co 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
US4427677A (en) * 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
GR76342B (enExample) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016512257A (ja) * 2013-03-13 2016-04-25 セラヴァンス バイオファーマ アンチバイオティクス アイピー， エルエルシー 置換チアゾリル酢酸トリエチルアミン塩の結晶形態

Also Published As

Publication number Publication date
EP0055465A3 (en) 1983-11-30
US4438113A (en) 1984-03-20
EP0055465B1 (en) 1989-08-23
JPH0359070B2 (enExample) 1991-09-09
US4596829A (en) 1986-06-24
EP0055465A2 (en) 1982-07-07
US4925948A (en) 1990-05-15
DE3177090D1 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
EP0244637B1 (en) Starting compounds for 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for their preparation
US4559334A (en) 7-Substituted-3-vinyl-3-cephem compounds and processes for production of the same
JPH0359070B2 (enExample)
US5336673A (en) 3-substituted cephem compounds
JPH02300191A (ja) ７―アシルアミノ―３―置換セファロスポラン酸誘導体
JPS63146863A (ja) カルボン酸類
JPS60100585A (ja) 新規セフエム化合物およびその製造法
JPH02149585A (ja) セフアロスポリン誘導体、その製造法および該化合物を含有する抗菌作用を有する製薬学的組成物
JPS5859991A (ja) 新規セフェム化合物
US4943567A (en) Cephalosporin compound and pharmaceutical composition thereof
JPH0327552B2 (enExample)
EP0105459B1 (en) Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them
EP0267733A2 (en) Cephalosporin compounds, process for their preparation and pharmaceutical compositions containing them
DE68920474T2 (de) Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
US4492692A (en) Cephalosporin derivatives
US4065619A (en) 7-(α-Sulfoacylamido)cephalosporins
JPS6133190A (ja) 新規セフエム化合物，その製造法およびその用途
DE2620094A1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
KR870000611B1 (ko) 세팔로스포린의 제조방법
JPS6163684A (ja) 新規セフエム化合物およびその製造法
KR840001989B1 (ko) 7-아실아미노-3-비닐세팔로스포란산 유도체의 제조방법
JPS58135894A (ja) ７―置換ブチルアミド―３―ビニルセファロスポラン酸誘導体
JPH0530836B2 (enExample)
AT371822B (de) Verfahren zur herstellung von neuen cephalosporansaeurederivaten
JPS60190783A (ja) セフエム系化合物